Cargando…
Author Correction: mTORC1 Maintains the Tumorigenicity of SSEA-4 (+) High-Grade Osteosarcoma
Autores principales: | Zhang, Wu, Ding, Meng-Lei, Zhang, Jia-Nian, Qiu, Jian-Ru, Shen, Yu-Hui, Ding, Xiao-Yi, Deng, Lian-Fu, Zhang, Wei-Bin, Zhu, Jiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551168/ https://www.ncbi.nlm.nih.gov/pubmed/34707225 http://dx.doi.org/10.1038/s41598-021-00930-2 |
Ejemplares similares
-
mTORC1 Maintains the Tumorigenicity of SSEA-4(+) High-Grade Osteosarcoma
por: Zhang, Wu, et al.
Publicado: (2015) -
Author Correction: Activation of lysosomal mediated cell death in the course of autophagy by mTORC1 inhibitor
por: Khan, Sameer Ullah, et al.
Publicado: (2022) -
Author Correction: A Rag GTPase dimer code defines the regulation of mTORC1 by amino acids
por: Gollwitzer, Peter, et al.
Publicado: (2022) -
Author Correction: Inhibition of the Akt1-mTORC1 Axis Alters Venous Remodeling to Improve Arteriovenous Fistula Patency
por: Guo, Xiangjiang, et al.
Publicado: (2020) -
Author Correction: mTORC2-AKT signaling to ATP-citrate lyase drives brown adipogenesis and de novo lipogenesis
por: Calejman, C. Martinez, et al.
Publicado: (2020)